Enveric Biosciences

Enveric Biosciences is a patient-centric biotechnology company dedicated to improving the lives of patients adversely affected by the side effects of cancer treatment. Enveric Biosciences aims to rigorously test natural compounds, starting with cannabinoids, to provide new prescription medications for patients and clinicians to address these unmet medical needs. Biosciences fully leverages innovative clinical development achievements in cannabinoid-based drugs and utilizes its global network of scientists and oncologists.AMERI Holdings, Inc. (NASDAQ: AMRH) officially completed the spin-off and tender offer on December 31, 2020. The company name was changed to Enveric Biosciences, Inc., and the stock trading symbol was changed to NASDAQ: ENVB.